| Bioactivity | Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity[1]. | ||||||
| Invitro | Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity[1]. | ||||||
| Name | Eptifibatide | ||||||
| CAS | 188627-80-7 | ||||||
| Sequence | MPA-HAR-Gly-Asp-Trp-Pro-Cys-NH2 | ||||||
| Shortening | MPA-HAR-GDWPC-NH2 | ||||||
| Formula | C35H49N11O9S2 | ||||||
| Molar Mass | 831.96 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
Eptifibatide
CAS: 188627-80-7 F: C35H49N11O9S2 W: 831.96
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.